Audited annual filings, TTM ratios and consensus forward estimates
Wall Street price targets and rating actions
Revenue disaggregation per 10-K filing
Annual filings (FY) with consensus forward estimates (hatched)
1255 daily bars · split adjusted
Daily · Wilder smoothing
Classic floor pivots from 2026-10-23
Computed from daily OHLCV bars
| Indicator | Value | Type | Action |
|---|---|---|---|
| RSI (14) | 60.62 | Oscillator | Neutral |
| Stochastic %K (14, 3, 3) | 86.44 | Oscillator | Sell |
| Williams %R (14) | -20.99 | Oscillator | Neutral |
| MACD (12, 26, 9) | 0.78 (Hist 0.24) | Oscillator | Strong Buy |
| Average Directional Index (14) | 20.17 (+DI 27.5 / -DI 13.0) | Trend | Buy |
| EMA 20 | 30.12 | MA | Strong Buy |
| SMA 20 | 29.64 | MA | Strong Buy |
| EMA 50 | 29.44 | MA | Strong Buy |
| SMA 50 | 28.93 | MA | Strong Buy |
| SMA 200 | 25.36 | MA | Strong Buy |
Current price $31.51
Latest analyst grade actions
| Date | Firm | Action | Previous | New grade |
|---|---|---|---|---|
| Sep 23, 26 | Leerink Partners | maintain | Market Perform | Market Perform |
| Jul 30, 26 | Barclays | maintain | Equal Weight | Equal Weight |
| Jul 30, 26 | Guggenheim | maintain | Buy | Buy |
| Jul 20, 26 | Guggenheim | maintain | Buy | Buy |
| Jul 14, 26 | TD Cowen | maintain | Buy | Buy |
| Jul 14, 26 | Keybanc | maintain | Overweight | Overweight |
| Jul 9, 26 | UBS | maintain | Buy | Buy |
| Jun 3, 26 | Jefferies | upgrade | Hold | Buy |
| May 4, 26 | Guggenheim | maintain | Buy | Buy |
Free float vs. closely held shares
13F institutional holdings are not available in the current data plan.
SEC Form 4 filings
| Date | Insider | Role | Type | Shares @ price | Value |
|---|---|---|---|---|---|
| Jul 26, 26 | Farley Brian | officer: EVP, CLAO and Secretary | F-InKind | 1,770 @ $34.51 | $61.08K |
| Jun 26, 26 | Farley Brian | officer: EVP, CLAO and Secretary | F-InKind | 1,370 @ $26.24 | $35.95K |
| May 1, 26 | Duckworth David M. | officer: Interim CFO | 0 | — | |
| May 6, 26 | Fucci Michael | director | A-Award | 6,331 | — |
| May 6, 26 | Kelly Ralph David | director | A-Award | 6,331 | — |
| May 6, 26 | Gregg Vicky B | director | A-Award | 6,331 | — |
| May 6, 26 | Bernhard Jason | director | A-Award | 5,124 | — |
| May 6, 26 | Bernhard Jason | director | A-Award | 6,331 | — |
Stock news · updated daily
Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.
FRANKLIN, Tenn.--(BUSINESS WIRE)--Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that it will release its third quarter 2026 results on Wednesday, November 4, 2026, after the close of the market. Acadia will host a conference call with institutional investors and analysts on Thursday, November 5, 2026 at 9:00 a.m. ET. A live broadcast of the conference call will be available at www.acadiahealthcare.com in the “Investors” section of the website, and the archived webcast will be a.
Acadia Healthcare (ACHC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Acadia Healthcare Company, Inc. (NASDAQ: ACHC - Get Free Report)'s stock price passed above its two hundred day moving average during trading on Monday. The stock has a two hundred day moving average of $27.53 and traded as high as $28.92. Acadia Healthcare shares last traded at $28.87, with a volume of 2,431,127 shares trading hands.
Acadia Healthcare (ACHC) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Here is how Acadia Healthcare (ACHC) and Brookdale Senior Living (BKD) have performed compared to their sector so far this year.
Wall Street analysts are making bold moves as the third quarter closes, with major calls hitting PepsiCo, Roblox, Snowflake, and a Bitcoin infrastructure stock carrying a price target that will turn heads.
FRANKLIN, Tenn.--(BUSINESS WIRE)--Acadia Healthcare Company, Inc. (“Acadia” or the “Company”) (NASDAQ: ACHC) issues the below summary notice of proposed settlement as provided for in the September 1, 2026 order providing preliminary approval issued by the United States District Court for the Middle District of Tennessee. UNITED STATES DISTRICT COURT MIDDLE DISTRICT OF TENNESSEE NASHVILLE DIVISION IN RE ACADIA HEALTHCARE COMPANY, INC. STOCKHOLDER DERIVATIVE LITIGATION Lead Case No. 3:19-cv-00167.
Reported EPS vs. consensus estimate
| Report date | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|
| Jul 28, 2026 | 0.35 | 0.38 | Beat 9.7% | $865.8M |
| Apr 29, 2026 | 0.28 | 0.37 | Beat 32.1% | $828.8M |
| Feb 25, 2026 | 0.03 | 0.07 | Beat 133.3% | $821.5M |
| Nov 5, 2025 | 0.68 | 0.72 | Beat 5.9% | $851.6M |
| Aug 5, 2025 | 0.71 | 0.83 | Beat 16.9% | $869.2M |
| May 12, 2025 | 0.35 | 0.40 | Beat 14.3% | $770.5M |
SEC EDGAR filings · last 12 months
| Form | Filed | Accepted | Document |
|---|---|---|---|
| SC 13G | Oct 8, 2026 | 2026-10-08 14:25:42 | View |
| 8-K | Sep 25, 2026 | 2026-09-25 16:12:41 | View |
| SC 13G/A | Aug 14, 2026 | 2026-08-14 06:35:04 | View |
| SC 13G/A | Aug 13, 2026 | 2026-08-13 16:08:32 | View |
| SC 13G/A | Aug 6, 2026 | 2026-08-06 10:14:38 | View |
| 8-K | Jul 28, 2026 | 2026-07-28 16:57:17 | View |
| 10-Q | Jul 28, 2026 | 2026-07-28 16:30:44 | View |
| 4 | Jul 27, 2026 | 2026-07-27 17:01:03 | View |
| SC 13G/A | Jul 27, 2026 | 2026-07-27 16:25:23 | View |
| 4 | Jun 26, 2026 | 2026-06-26 17:01:02 | View |
Proxy statement (DEF 14A) disclosures
FY2025 · 10-K disclosure
TTM vs. 5-year historical average (annual ratios)
| Metric | ACHC | Historical (5Y) / ref | Status |
|---|---|---|---|
| P/E ratio (TTM) | -2.5x | -51.1x · sector 20.7x | Discount |
| Forward P/E (FY26E) | 20.6x | EPS est. 1.53 | Discount |
| Price / Book | 1.4x | 1.8x | Discount |
| Price / Sales | 0.9x | 1.8x | Discount |
| EV / EBITDA | -7.8x | 15.9x | Discount |
| Return on equity | -50.0% | — | Weak |
| Gross margin | 35.6% | 51.1% | Below hist. |
| Debt / Equity | 1.30 | 0.76 | Moderate |
| Piotroski / Altman Z | 4/9 | Z 0.49 | Distress |
Discounted cash flow model